Ioana Aanei, Ph.D.
Director, Business Development and Alliance Management, Scribe Therapeutics
Ioana Aanei, Ph.D., is director of business development and alliance management at Scribe Therapeutics. As one of the company’s earliest employees, she helped establish collaborations with major pharmaceutical companies that secured more than $155 million in upfront payments and more than $4 billion in potential milestones. She also helped secure more than $25 million in nondilutive funding from the California Institute for Regenerative Medicine. She previously helped build the QB3 entrepreneurial ecosystem.